SCHEMBL26650942

SCHEMBL26650942

COc1c(C=O)cn(S(=O)(=O)c2cccc(C)n2)c1-c1ccc(F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ PKM P14618 1/20 0.32
▸ F2RL3 Q96RI0 1/20 0.32
▸ AR P10275 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ SCN9A Q15858 1/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ HTR2A P28223 1/20 0.30
▸ HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25313711 0.90 NFE2L2 (0.35) SMN1; SMN2HSD17B10POLBKMT2APKM
SCHEMBL28996436 0.84 GRM5 (0.38) GRM5SMN1; SMN2HSD17B10POLBKMT2A
SCHEMBL28996388 0.83 GRM5 (0.42) GRM5SMN1; SMN2HSD17B10POLBKMT2A
SCHEMBL30963578 0.83 MEN1 (0.40) SMN1; SMN2POLBKMT2AKDM4EPTGS1
SCHEMBL19385625 0.83 MEN1 (0.40) SMN1; SMN2POLBKMT2AKDM4EPTGS1
SCHEMBL25436123 0.82 GRM5 (0.39) GRM5SMN1; SMN2HSD17B10POLBKMT2A
SCHEMBL26651006 0.81 PTGS2 (0.36) SMN1; SMN2HSD17B10POLBKMT2AKDM4E
SCHEMBL30287361 0.81 PTGS2 (0.36) SMN1; SMN2HSD17B10POLBKMT2AKDM4E
SCHEMBL25317303 0.80 SMN1; SMN2 (0.41) GRM5SMN1; SMN2HSD17B10POLBKMT2A
SCHEMBL25316119 0.79 NFE2L2 (0.39) GRM5POLBF2RL3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115884968-B Novel acid secretion inhibitor and use thereof 日东制药株式会社 2024-06-21 — — CN disclosed
US-20230373954-A1 NOVEL ACID SECRETION INHIBITOR AND USE THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-23 — — US disclosed
CN-115884968-A Novel acid secretion inhibitor and use thereof 日东制药株式会社 2023-03-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373954-A1 NOVEL ACID SECRETION INHIBITOR AND USE THEREOF SLC10A2, SLC10A1, ASIC1 GRM5 1753/4885SMN1; SMN2 4413/4885HSD17B10 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback